Evidence map›Paper›PMID 40131210›Full record

ArticleBioanalysis2025

Feedback from the 10th European Bioanalysis Forum Young Scientist Symposium and from the Science Café discussions on sustainability in bioanalysis.

Sanam Ahmad, Fabian Gärtner, Rosie Penford, Lisa Wolter, Sonya Belle, Alexandra Bushby, Mariana Carneiro Da Cunha, Brian Dan, Andrea Di Ianni, Caroline Dumolyn and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioanalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Sanam AhmadGSK, Biomarker and Bioanalytical Platforms, Precision Medicine, Stevenage, UK.
Fabian GärtnerNuvisan GmbH, Bioanalysis, Neu-Ulm, Germany.
Rosie PenfordAstraZeneca, Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, Cambridge, UK.
Lisa WolterAbbVie Deutschland GmbH & Co. KG, Quantitative, Translational & ADME Sciences, Ludwigshafen, Rhein, Germany.
Sonya BelleCharles River Laboratories Edinburgh Ltd, Edinburgh, UK.
Alexandra BushbyLabcorp Early Development Laboratories Limited; Bioanalytical Services Harrogate; HG3 1PY, UK.
Mariana Carneiro Da CunhaIntertek Pharmaceutical Services, Bioanalytical, Immunoassay, Manchester, UK.
Brian DanRoche Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Andrea Di IanniMerck KGaA, R&D, New Biological Entities Drug Metabolism Pharmacokinetics, Innovative BioAnalytics, Colleretto Giacosa, TO, Italy.
Caroline DumolynSanofi, Bioanalysis and Immunogenicity, DMPK, Zwijnaarde, Belgium.
Marie Sole GiordanoSwiss BioQuant, Biochemical Analysis, Reinach, BL, Switzerland.
Eva HanckmannByondis B.V. Department of Bioanalysis & Protein Interaction, Nijmegen, the Netherlands.
Jayshree MaherModerna Innovation and Technology Centre (Harwell), Harwell, UK.
Elisa MilandriDepartment of Pharmacy and Biotechnology (FaBiT), Research Group of Pharmaco-Toxicological Analysis (PTA Lab), Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Kyriel PineaultUCB Biopharma SRL, Translational Biomarker & Bioanalysis, Braine-l'Alleud, Belgium.
Amelia RobertsQuotient Sciences, Bioanalytical Services, Alnwick, UK.
Marie Reille-SeroussiSanofi, Bioanalysis and Immunogenicity, DMPK, Frankfurt am Main, Germany.
Sara RussoICON, Bioanalytical Laboratories, Assen, The Netherlands.
Manca SpendalNovo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, Maaløv, Denmark.
Claire SzusterResolian Bioanalytics, Fordham, UK.
Kevin VandenbrouckeLaboratory of Toxicology, Ghent University, Ghent, Belgium.
Aline VollmerDepartment of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Friederike VogtBioAgilytix Laboratories, Hamburg, Germany.
Simon WellenbergDepartment of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Philip TimmermanEuropean Bioanalysis Forum, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2014, the European Bioanalysis Forum has organized the Young Scientist Symposium, providing early-career scientists with unique development opportunities. By fostering a peer community, this initiative has successfully lowered barriers to engagement in cross-company, pre-competitive interactions. Since 2018, the symposium has included the Science Café roundtable, further reinforcing the European Bioanalysis Forum's commitment to supporting young scientists beyond their scientific expertise by promoting broader professional development.This manuscript summarizes discussions from the 10th Young Scientist Symposium, held in Hasselt, Belgium, from May 15-17, 2024. The symposium featured presentations on new technologies, biomarker assays, troubleshooting, and microsampling. Additionally, it provides insights from the Science Café discussions, which focused on sustainability in the bioanalytical laboratory.

Indexed as

Chemistry Techniques, AnalyticalBiomarkersCongresses as TopicEuropeHumansBiomarkersbiomarkersmicrosamplingnew technologiesscience cafétroubleshootingYoung scientist symposium

Identifiers

PMID40131210
PMCPMC12087919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.